The Pharmacology Center

Filter Your Results

 

News

 

ACC/AHA Publish 2016 Focused Update of Guidelines for DAPT

March 31, 2016 -- The American College of Cardiology (ACC) and the American Heart Association (AHA) jointly released updated guidelines for dual-antiplatelet therapy (DAPT) in…

Amgen Wins Patent Case for Its Repatha PCSK9 Against Sanofi and Regeneron’s Praluent PCSK9

March 16, 2016 -- Amgen announced that a Delaware jury delivered a verdict in the company’s favor in a trial on the validity of two Amgen patents that describe and claim…

Meta-Analysis Evaluates Medicure’s Aggrastat for PCI Patients

February 23, 2016 -- Medicure Inc. announced the presentation of a study, “Comparison of High-Dose Bolus Tirofiban With Other Anticoagulation Strategies for Percutaneous…

Studies Presented for BioCardia’s CardiAMP Cell Therapy

February 22, 2016 -- BioCardia, Inc. announced that two presentations related to the company’s CardiAMP cell therapy were presented at CRT 2016, the Cardiovascular Resea…

Ablative Solutions Commences European Peregrine Postmarket Study for Renal Denervation

February 16, 2016 -- Ablative Solutions, Inc. announced that Professors Wojtek Wojakowski, MD, and Mariusz Hochul, MD, have treated the first two patients in the European Pere…

Substudy of I-LOVE-IT 2 Supports 6-Month DAPT After Biodegradable SES Implantation

February 16, 2016 -- Yaling Han, MD, et al published the outcomes of a randomized substudy on the duration of dual-antiplatelet therapy (DAPT) in the prospective I-LOVE-IT 2 t…

DAPT in STEMI

With Moderator Andrey Espinoza, MD, FACC, FSCAI; and Panelists Peter B. Berger, MD; Paul A. Gurbel, MD; Charles Pollack, MA, MD, FACEP, FAAEM; and Marc Cohen, MD, FACC

January/February 2016—A panel of experts weighs in on STEMI pharmacology, transmission of prehospital ECGs by emergency medical services, and STEMI best practices for 2016.

Optimal Duration of DAPT

Sammy Elmariah, MD, MPH, FACC, FAHA

January/February 2016—Data and implications of recent trials.

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.